SCHEDULE: Pentwater Capital Discloses 6.1% Stake in Masimo Corp

Pentwater Capital Management LP and Matthew Halbower have filed a Schedule 13G reporting a 6.1% beneficial ownership stake in Masimo Corp.

Summary

• Pentwater Capital Management LP and Matthew Halbower reported beneficial ownership of 3,176,000 shares of Masimo Corp. common stock.
• The reported stake represents 6.1% of the company's total outstanding common stock.
• The ownership percentage is based on 52,362,808 shares outstanding as of March 31, 2026.
• The filing is a passive investment disclosure under Schedule 13G, indicating the shares were acquired in the ordinary course of business without the intent to change or influence control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming institutional interest without signaling immediate activist intent.

Positives

• Institutional investor confidence demonstrated by the accumulation of a significant 6.1% equity position.

Negatives

• None identified in this regulatory disclosure.

Risks

• Market volatility affecting the value of the investment.
• Potential for future changes in investment intent if market conditions or company performance shift.

Future Outlook

The filing states the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Management Comments

• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional filings of this nature are standard in the medical technology sector, where large hedge funds often take significant positions in companies undergoing strategic shifts or valuation adjustments.

Comparison to Industry Standards

• The 6.1% stake is a standard threshold for institutional disclosure, consistent with typical activist or passive investment patterns in mid-cap medical device companies.
• The filing follows standard SEC reporting requirements for investment managers holding over 5% of a public company.

Stakeholder Impact

• Shareholders may view the entry of a significant institutional investor as a signal of potential value or stability in the company's long-term outlook.

Next Steps

• The reporting persons are responsible for filing future amendments to this statement if there are material changes in their ownership percentage.

Key Dates

Recommendation

The filing indicates institutional accumulation, which is generally positive, but the passive nature of the investment suggests no immediate catalyst for change, warranting a hold position until further strategic developments occur.

Keywords

Masimo Corp, Pentwater Capital Management, Schedule 13G, Institutional Ownership, Equity Stake, Matthew Halbower